press release

Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide NEW YORK, NY, UNITED STATES, March 11, 2020 /EINPresswire.com/ -- Laidlaw Wealth Management is pleased to announce it has chosen Envestnet, a leading provider of intelligent systems for wealth management and financial wellness, to provide Laidlaw advisors with access to their leading, Read More...

Laidlaw Capital Markets is pleased to announce today's pricing of a $21,750,000 Follow-On Offering for EyePoint Pharmaceuticals (EYPT). Laidlaw proudly served as Co-Manager alongside Guggenheim, who was Sole Book-Runner on the transaction. See full Press Release on Eyepoint Website

Laidlaw Capital Markets is pleased to announce today's pricing of a $10,000,000 Follow-On Offering for BioSig Technologies (BSGM). Laidlaw proudly served as the Sole Book Runner on the transaction. See full Press Release on BioSig Website

Laidlaw Capital Markets is pleased to announce today’s pricing of a $90,000,000 Follow-On Offering for Ziopharm Oncology (ZIOP). Laidlaw proudly served as Co-Manager alongside Jefferies, who was Sole-Book Runner on the transaction. See full Press Release on Ziopharm Website

The Laidlaw Capital Markets team is pleased to announce our role as a Financial Advisor to Beyond Air Inc (XAIR) on this mornings $11,500,000 Follow-On Offering led by Suntrust Robinson. Laidlaw acted as Sole Placement Agent on a $10,000,000 PIPE in 2018 and this is the third transaction we have been involved in with the Read More...

Laidlaw Wealth Management Boosts Investment Offering With Green Harvest Deal December 12, 2019 12:21 PM Eastern Standard Time NEW YORK--(BUSINESS WIRE)--Laidlaw Wealth Management is pleased to announce that it is expanding its collaboration with Green Harvest Asset Management. The relationship will give Laidlaw Advisors access to Green Harvest’s ProActive Tax Management investment strategies which Read More...

Laidlaw Capital Markets is pleased to announce today's pricing of Affimed (AFMD). Laidlaw served as Co-Manager, alongside Jefferies and SVB Leerink, for the $34,500,000 Follow-On Offering. See full Press Release on Affimed Website

Laidlaw Capital Markets is pleased to serve as Financial Advisor to Molecular Templates (MTEM) on the pricing of its $50,000,000 Follow-On Offering. This is Laidlaw's second transaction in the syndicate, helping raise more than $100,000,000 in capital for the company in the last 15 months. See full Press Release on Molecular Templates Website Read More...

Laidlaw Capital Markets is pleased to announce today's pricing of Soleno Therapeutics (SLNO). Laidlaw served as Co-Manager for the $15,400,000 Follow-On Offering. See full Press Release on SOLENO Website

Laidlaw on a Recruiting Tear in 2019. Over Half a Billion Recruited in First Half of Year With Recent Addition of $250 Million, 35-Year Morgan Stanley Veteran